Respiratory Infections
Latest News
April 29th 2025
The agencies are calling for sustained investments in immunization efforts in the midst of increasing case numbers rising for diseases such as whooping cough, measles, and others.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice
View More
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
Burst CME™: Stepping Up Care for Patients With PAH
View More
More News
DNA Sequencing Could Lead to More Accurate Pneumonia Diagnosis
December 2nd 2014A team of researchers at George Washington University has reported that next-generation sequencing of sputum samples taken from patients in the intensive care unit can accurately identify the strain of ventilator-associated pneumonia a patient is infected with.
Read More
Benefits of Azithromycin Outweigh Risks in Elderly Hospitalized with Pneumonia
September 11th 2014Among patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.
Read More
